Rodolfo Bautista Ganzon, MD in Matthews, NC - Medicare Hospitalist

Rodolfo Bautista Ganzon, MD is a medicare enrolled "Hospitalist" physician in Matthews, North Carolina. He graduated from medical school in 1988 and has 36 years of diverse experience with area of expertise as Hospitalist. He is a member of the group practice Novant Medical Group Inc, Novant Health Matthews Medical Center Llc and his current practice location is 1500 Matthews Township Pkwy, Matthews, North Carolina. You can reach out to his office (for appointments etc.) via phone at (704) 384-9740.

Rodolfo Bautista Ganzon is licensed to practice in North Carolina (license number 200100871) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1245259365.

Contact Information

	Rodolfo Bautista Ganzon, MD
	1500 Matthews Township Pkwy, Matthews, NC 28105-4656
	(704) 384-9740
	(704) 384-9565

Physician's Profile

Full Name	Rodolfo Bautista Ganzon
Gender	Male
Speciality	Hospitalist
Experience	36 Years
Location	1500 Matthews Township Pkwy, Matthews, North Carolina
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Rodolfo Bautista Ganzon graduated from medical school in 1988

NPI Data:

NPI Number: 1245259365
Provider Enumeration Date: 07/19/2006
Last Update Date: 10/25/2020

Medicare PECOS Information:

PECOS PAC ID: 9537265129
Enrollment ID: I20070427000143

Medical Identifiers

Medical identifiers for Rodolfo Bautista Ganzon such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1245259365	NPI	-	NPPES
12994	Other	NC	BC BS NC
110236348	Other	NC	RR MEDICARE
N00878	Medicaid	SC
8912994	Medicaid	NC

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207R00000X	Internal Medicine	200100871 (North Carolina)	Secondary
208M00000X	Hospitalist	200100871 (North Carolina)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Novant Health Matthews Medical Center	Matthews, NC	Hospital
Novant Health Presbyterian Medical Center	Charlotte, NC	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Novant Medical Group Inc	1153234893	1996
Novant Health Matthews Medical Center Llc	6406845247	56

News Archive

Study shows that ankylosing spondylitis can be predicted by low birth weight

The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that a diagnosis of ankylosing spondylitis (AS) can be predicted by low birth weight, having older siblings and hospitalisation for infection between the ages of 5-16 years.

SMFM praises FDA's announcement on Makena drug

The Society for Maternal-Fetal Medicine weighed in on today's FDA announcement to continue to allow pharmacies to compound hydroxyprogesterone caproate, also known as 17P.

CWHI launches to combat the effects of climate change on vulnerable populations

The Center for Health, Work & Environment at the Colorado School of Public Health and the Colorado Consortium on Climate Change and Human Health have launched the Climate, Work & Health Initiative.

New drug compound Salirasib brings hope to pancreatic cancer patients

Every year, 42,000 Americans are diagnosed with pancreatic cancer. Few live very long, and less than 5% are still alive five years after diagnosis.

Enzon in collaboration with NCI initiates EZN-2968, EZN-2208 Phase I studies for arresting tumor growth

Enzon Pharmaceuticals, today announced the initiation of Phase I clinical studies, in collaboration with the National Cancer Institute, for two of the Company's novel oncology product candidates, EZN-2968 and EZN-2208 (PEG-SN38).

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Rodolfo Bautista Ganzon allows following entities to bill medicare on his behalf.

Entity Name	Novant Medical Group Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1366409492 PECOS PAC ID: 1153234893 Enrollment ID: O20031121000692

News Archive

Study shows that ankylosing spondylitis can be predicted by low birth weight

SMFM praises FDA's announcement on Makena drug

The Society for Maternal-Fetal Medicine weighed in on today's FDA announcement to continue to allow pharmacies to compound hydroxyprogesterone caproate, also known as 17P.

CWHI launches to combat the effects of climate change on vulnerable populations

The Center for Health, Work & Environment at the Colorado School of Public Health and the Colorado Consortium on Climate Change and Human Health have launched the Climate, Work & Health Initiative.

New drug compound Salirasib brings hope to pancreatic cancer patients

Every year, 42,000 Americans are diagnosed with pancreatic cancer. Few live very long, and less than 5% are still alive five years after diagnosis.

Enzon in collaboration with NCI initiates EZN-2968, EZN-2208 Phase I studies for arresting tumor growth

Entity Name	Novant Health Matthews Medical Center Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1184782419 PECOS PAC ID: 6406845247 Enrollment ID: O20051114000445

Study shows that ankylosing spondylitis can be predicted by low birth weight

SMFM praises FDA's announcement on Makena drug

The Society for Maternal-Fetal Medicine weighed in on today's FDA announcement to continue to allow pharmacies to compound hydroxyprogesterone caproate, also known as 17P.

CWHI launches to combat the effects of climate change on vulnerable populations

The Center for Health, Work & Environment at the Colorado School of Public Health and the Colorado Consortium on Climate Change and Human Health have launched the Climate, Work & Health Initiative.

New drug compound Salirasib brings hope to pancreatic cancer patients

Every year, 42,000 Americans are diagnosed with pancreatic cancer. Few live very long, and less than 5% are still alive five years after diagnosis.

Enzon in collaboration with NCI initiates EZN-2968, EZN-2208 Phase I studies for arresting tumor growth

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Rodolfo Bautista Ganzon is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Rodolfo Bautista Ganzon, MD Po Box 60447, Charlotte, NC 28260-0447 Ph: (704) 384-9740	Rodolfo Bautista Ganzon, MD 1500 Matthews Township Pkwy, Matthews, NC 28105-4656 Ph: (704) 384-9740

News Archive

Study shows that ankylosing spondylitis can be predicted by low birth weight

SMFM praises FDA's announcement on Makena drug

The Society for Maternal-Fetal Medicine weighed in on today's FDA announcement to continue to allow pharmacies to compound hydroxyprogesterone caproate, also known as 17P.

CWHI launches to combat the effects of climate change on vulnerable populations

The Center for Health, Work & Environment at the Colorado School of Public Health and the Colorado Consortium on Climate Change and Human Health have launched the Climate, Work & Health Initiative.

New drug compound Salirasib brings hope to pancreatic cancer patients

Every year, 42,000 Americans are diagnosed with pancreatic cancer. Few live very long, and less than 5% are still alive five years after diagnosis.

Enzon in collaboration with NCI initiates EZN-2968, EZN-2208 Phase I studies for arresting tumor growth

Hospitalist Doctors in Matthews, NC

Dr. Reena Khetpal, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-384-9740 Fax: 704-384-9565
Naveen Bandarupalli, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-384-5416 Fax: 704-384-5992
Dr. Amine Segueni, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 630 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-495-6020
Dr. Akshay Pendyal, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1401 Matthews Township Pkwy Ste 212, Matthews, NC 28105 Phone: 704-316-3131 Fax: 704-316-3132
Eva Agocs, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-384-5416 Fax: 704-384-5992
Dr. Vijay Kumar Talreja, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-384-9740 Fax: 704-384-9565

Rodolfo Bautista Ganzon, MD - Medicare Hospitalist in Matthews, NC

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Study shows that ankylosing spondylitis can be predicted by low birth weight

SMFM praises FDA's announcement on Makena drug

CWHI launches to combat the effects of climate change on vulnerable populations

New drug compound Salirasib brings hope to pancreatic cancer patients

Enzon in collaboration with NCI initiates EZN-2968, EZN-2208 Phase I studies for arresting tumor growth

Medicare Reassignments

Study shows that ankylosing spondylitis can be predicted by low birth weight

SMFM praises FDA's announcement on Makena drug

CWHI launches to combat the effects of climate change on vulnerable populations

New drug compound Salirasib brings hope to pancreatic cancer patients

Enzon in collaboration with NCI initiates EZN-2968, EZN-2208 Phase I studies for arresting tumor growth

Study shows that ankylosing spondylitis can be predicted by low birth weight

SMFM praises FDA's announcement on Makena drug

CWHI launches to combat the effects of climate change on vulnerable populations

New drug compound Salirasib brings hope to pancreatic cancer patients

Enzon in collaboration with NCI initiates EZN-2968, EZN-2208 Phase I studies for arresting tumor growth

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Study shows that ankylosing spondylitis can be predicted by low birth weight

SMFM praises FDA's announcement on Makena drug

CWHI launches to combat the effects of climate change on vulnerable populations

New drug compound Salirasib brings hope to pancreatic cancer patients

Enzon in collaboration with NCI initiates EZN-2968, EZN-2208 Phase I studies for arresting tumor growth

Hospitalist Doctors in Matthews, NC